Diltiazem

Diltiazem
(IUPAC) ime
	cis-(+)-[2-(2-dimetilaminoetil)-5-(4-metoksifenil); -3-okso-6-tia-2-azabiciklo[5.4.0]undeka-7,9,; 11-trien-4-il]etanoat
Klinički podaci
Robne marke	Cardizem, Dilacorxr
AHFS/Drugs.com	Monografija
MedlinePlus	a684027
Identifikatori
CAS broj	42399-41-7
ATC kod	C08DB01
PubChem	39186
DrugBank	DB00343
ChemSpider	35850
UNII	EE92BBP03H
KEGG	D07845
ChEBI	CHEBI:101278
ChEMBL	CHEMBL23
Hemijski podaci
Formula	C22H26N2O4S
Mol. masa	414,519 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C22H26N2O4S/c1-15(25)28-20-21(16-9-11-17(27-4)12-10-16)29-19-8-6-5-7-18(19)24(22(20)26)14-13-23(2)3/h5-12,20-21H,13-14H2,1-4H3/t20-,21+/m1/s1 ; Key: HSUGRBWQSSZJOP-RTWAWAEBSA-N
Farmakokinetički podaci
Bioraspoloživost	40%
Metabolizam	Hepatički
Poluvreme eliminacije	3–4,5 sata
Izlučivanje	Renalno; Bilijarno
Farmakoinformacioni podaci
Trudnoća	?
Pravni status
Način primene	Oralno

Diltiazem je član klase lekova koji su blokatori kalcijumskih kanala. Ovaj lek ne sadrži dihidropiridin. On se koristi za tretiranje hipertenzije, angine pektoris, i pojedinih tipova aritmije. On je teratogen.^[6]^[7]

On je takođe efektivan u prevenciji migrene. On je česta primesa kokaina zaplenjenog u Velikoj Britaniji.^[8] Poznato je da redukuje želju za kokainom kod pacova.

Diltiazem je supstrat i inhibitor enzima CYP3A4.

Reference uredi

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
↑ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. PMID 21059682.
↑ Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. PMID 18048412.
↑ „Full list of impurities found in cocaine”. BBC. 12. 5. 2009..

Spoljašnje veze uredi

	Portal Medicina
	Portal Hemija

U.S. National Library of Medicine: Drug Information Portal – Diltiazem

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

[4] Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.

[5] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

[6] Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. PMID 21059682.

[7] Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. PMID 18048412.

[8] „Full list of impurities found in cocaine”. BBC. 12. 5. 2009..

[6]

[7]

[1]

[2]

[3]

[4]

[5]

[8]